Roy Meckler
Neurology · Louisville, KYNPI 1578543344
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 316 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,809 and has fallen 89.5% since, to $295 in 2022.
Across 316 payments — averaging $15.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$852
- Biogen$751
- Novartis$394
- EMD Serono, Inc.$346
- Sunovion Pharmaceuticals Inc.$335
- E.r. Squibb & Sons, L.L.C.$282
- plus $2K from 24 others
What the payments were for
- Speaking & faculty fees$1543%
- Food & beverage$4,78496%
- Education$541%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 44 | $852 |
| Biogen | 44 | $751 |
| Novartis | 34 | $394 |
| EMD Serono, Inc. | 16 | $346 |
| Sunovion Pharmaceuticals Inc. | 23 | $335 |
| E.r. Squibb & Sons, L.L.C. | 3 | $282 |
| UCB, Inc. | 18 | $254 |
| Genentech USA, Inc. | 14 | $239 |
| AbbVie(2 entities) | 26 | $196 |
| Acorda Therapeutics, Inc | 11 | $154 |
| Biohaven Pharmaceuticals, Inc. | 6 | $131 |
| Mallinckrodt Enterprises LLC | 9 | $128 |
| Teva Pharmaceuticals USA, Inc. | 18 | $125 |
| Sanofi | 8 | $124 |
| AstraZeneca(2 entities) | 7 | $112 |
| Lilly USA, LLC | 8 | $104 |
| Bristol Myers Squibb | 1 | $97 |
| Avanir Pharmaceuticals, Inc. | 5 | $69 |
| Neurocrine Biosciences, Inc. | 4 | $51 |
| Mallinckrodt Hospital Products Inc. | 3 | $49 |
| Supernus Pharmaceuticals, Inc. | 3 | $36 |
| Jazz Pharmaceuticals Inc. | 2 | $28 |
| Lundbeck LLC | 2 | $27 |
| MDD US Operations, LLC | 1 | $20 |
| Merz North America, Inc. | 1 | $18 |
| Assertio Therapeutics, Inc. | 1 | $15 |
| Adamas Pharmaceuticals, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,991 in reported general payments places this provider in the 65th percentile of 210 neurology providers in Kentucky.
Other neurology in Louisville
- Brian PlatoLouisville$232K
- Kristi NordLouisville$217K
- Angela HardwickLouisville$187K
- Peter HederaLouisville$185K
- Jeffrey FrankLouisville$181K
- Mohammad AlsorogiLouisville$111K
- Tad SeifertLouisville$99K
- Michael SweeneyLouisville$71K
- Michael SowellLouisville$60K
- David RobertsonLouisville$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.